A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients

Hydroxyurea and low dose thalidomide are low-cost, easily accessible Hb F inducing agents that have been found to decrease transfusion dependency among transfusion-dependent thalassemia patients. However, these drugs have not much been explored in a randomized controlled setting. The objective of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharjee, Urmimala, Khadwal, Alka, Shafiq, Nusrat, Lad, Deepesh, Sharma, Prashant, Das, Reena, Shukla, Prateek, Jain, Arihant, Prakash, Gaurav, Malhotra, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809516/
https://www.ncbi.nlm.nih.gov/pubmed/36620489
http://dx.doi.org/10.1007/s12288-022-01620-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809516/
https://www.ncbi.nlm.nih.gov/pubmed/36620489
http://dx.doi.org/10.1007/s12288-022-01620-3

Ejemplares similares